Objective To study the antileukemia and immunomodulating effect of T activated killer (T AK) cells induced by anti CD3 antibody and interleukin 2 costimulation and liposomal interleukin 2 (L IL 2) plus kappa selenocarrageenan (KSC) on L1210 leukemia mice.

• 目的研究抗CD3单克隆抗体与IL－2共同诱导的T－AK细胞和IL－2脂质体（L－IL－2）联合硒酸酯多糖（KSC）对L1210小鼠白血病的治疗作用。